Stockscreener 앱 받기
132.65
2.72%
-3.71
시간 외 거래:
132.90
0.25
+0.19%
전일 마감가:
$136.36
열려 있는:
$136.36
하루 거래량:
1.56M
Relative Volume:
1.10
시가총액:
$19.45B
수익:
$9.61B
순이익/손실:
$1.53B
주가수익비율:
12.68
EPS:
10.46
순현금흐름:
$1.85B
1주 성능:
-4.65%
1개월 성능:
+2.61%
6개월 성능:
-5.17%
1년 성능:
-35.04%
1일 변동 폭
$132.04
$136.36
1주일 범위
$132.04
$142.32
52주 변동 폭
$110.03
$206.70
Biogen Inc Stock (BIIB) Company Profile
명칭
Biogen Inc
전화
(781) 464-2000
주소
225 BINNEY STREET, CAMBRIDGE, MA
BIIB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BIIB
Biogen Inc
|
132.65 | 19.99B | 9.61B | 1.53B | 1.85B | 10.46 |
|
LLY
Lilly Eli Co
|
731.96 | 658.15B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
175.45 | 425.77B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
207.92 | 367.55B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.47 | 245.64B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
83.21 | 209.99B | 63.43B | 16.42B | 14.72B | 6.49 |
Biogen Inc Stock (BIIB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-21 | 재개 | Truist | Hold |
| 2025-04-28 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-04-04 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-11 | 개시 | Bernstein | Mkt Perform |
| 2025-01-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-16 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-10 | 재개 | BofA Securities | Neutral |
| 2024-12-09 | 다운그레이드 | Jefferies | Buy → Hold |
| 2024-11-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-31 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-10 | 재개 | Raymond James | Mkt Perform |
| 2024-02-14 | 재확인 | Needham | Buy |
| 2024-02-14 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-01-24 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-12-20 | 재개 | Cantor Fitzgerald | Overweight |
| 2023-12-07 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-07-27 | 개시 | Scotiabank | Sector Outperform |
| 2023-07-24 | 재확인 | UBS | Buy |
| 2023-05-01 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2023-04-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-26 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-10-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-07 | 업그레이드 | Argus | Hold → Buy |
| 2022-09-28 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2022-09-28 | 업그레이드 | Mizuho | Neutral → Buy |
| 2022-09-28 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-04-18 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-08 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-03 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-02-04 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-04 | 재확인 | Barclays | Equal Weight |
| 2022-02-04 | 재확인 | BofA Securities | Neutral |
| 2022-02-04 | 재확인 | Cowen | Outperform |
| 2022-02-04 | 재확인 | Morgan Stanley | Overweight |
| 2022-02-04 | 재확인 | Needham | Buy |
| 2022-02-04 | 재확인 | Oppenheimer | Outperform |
| 2022-02-04 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2022-02-04 | 재확인 | Robert W. Baird | Neutral |
| 2022-02-04 | 재확인 | Wedbush | Neutral |
| 2022-02-04 | 재확인 | Wells Fargo | Equal Weight |
| 2022-02-04 | 재확인 | Wolfe Research | Peer Perform |
| 2022-01-13 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-01-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | 재개 | Raymond James | Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Outperform |
| 2021-09-23 | 개시 | Needham | Buy |
| 2021-06-18 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2021-06-14 | 재확인 | Truist | Buy |
| 2021-06-11 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-06-10 | 업그레이드 | UBS | Neutral → Buy |
| 2021-06-08 | 업그레이드 | Atlantic Equities | Underweight → Neutral |
| 2021-06-08 | 재확인 | Barclays | Equal Weight |
| 2021-06-08 | 업그레이드 | Citigroup | Sell → Neutral |
| 2021-06-08 | 재확인 | H.C. Wainwright | Buy |
| 2021-06-08 | 재확인 | Jefferies | Buy |
| 2021-06-08 | 재확인 | Morgan Stanley | Overweight |
| 2021-06-08 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2021-06-08 | 업그레이드 | Robert W. Baird | Underperform → Neutral |
| 2021-06-08 | 재확인 | Stifel | Buy |
| 2021-06-08 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2021-06-07 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-06-07 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-06-07 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2021-02-05 | 다운그레이드 | DZ Bank | Buy → Hold |
| 2021-01-29 | 업그레이드 | Stifel | Hold → Buy |
| 2020-11-10 | 업그레이드 | DZ Bank | Hold → Buy |
| 2020-11-09 | 다운그레이드 | Atlantic Equities | Neutral → Underweight |
| 2020-11-09 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-11-09 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-11-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-11-04 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-11-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-11-04 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-07-27 | 업그레이드 | Morgan Stanley | Underweight → Overweight |
| 2020-06-22 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-06-22 | 재확인 | RBC Capital Mkts | Sector Perform |
| 2020-06-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-04-23 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2020-04-23 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-27 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2019-12-13 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2019-12-02 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
모두보기
Biogen Inc 주식(BIIB)의 최신 뉴스
HighTower Advisors LLC Has $1.60 Million Stock Position in Biogen Inc. $BIIB - MarketBeat
Biogen Inc. $BIIB Shares Purchased by Korea Investment CORP - MarketBeat
US FDA’s ARIA Analysis Adds Earlier Scan To Biogen/Eisai Leqembi Label - insights.citeline.com
Is Biogen Inc. stock ready for a breakoutRecession Risk & Technical Pattern Recognition Alerts - Newser
Visualizing Biogen Inc. stock with heatmapsWeekly Trade Recap & Verified Technical Trade Signals - Newser
Biogen Inc. stock underperforms Thursday when compared to competitors - MarketWatch
FDA recommends more monitoring of Alzheimer's patients on Eisai-Biogen's drug Leqembi - Reuters
FDA recommends more monitoring of Alzheimer's patients on Biogen's drug Leqembi - Reuters
Regulatory Vigilance and the Future of Biogen’s Leqembi: Balancing Innovation with Risk in Alzheimer’s Drug Development - AInvest
What does recent volatility data suggest for Biogen Inc.Volume Spike & Free Daily Entry Point Trade Alerts - Newser
Will a bounce in Biogen Inc. offer an exit2025 Technical Patterns & Real-Time Buy Signal Notifications - Newser
Evaluating Biogen Inc. with trendline analysisTrade Risk Summary & Expert Curated Trade Setup Alerts - Newser
Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study - Benzinga
Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight - GlobeNewswire Inc.
Stock Analysis | Biogen OutlookNavigating Bearish Signals Amid Mixed Analyst Sentiment - AInvest
Biogen Inc. stock chart pattern explainedJuly 2025 Recap & Fast Entry Momentum Alerts - Newser
Custom watchlist performance reports with Biogen Inc.Quarterly Profit Report & Stepwise Entry/Exit Trade Alerts - Newser
Biogen Inc. $BIIB Shares Purchased by FORA Capital LLC - MarketBeat
Altrinsic Global Advisors LLC Reduces Stake in Biogen Inc. $BIIB - MarketBeat
Causeway Capital Management LLC Raises Stock Position in Biogen Inc. $BIIB - MarketBeat
Synovus Financial Corp Grows Stock Holdings in Biogen Inc. $BIIB - MarketBeat
Campbell & CO Investment Adviser LLC Reduces Stock Position in Biogen Inc. $BIIB - MarketBeat
APG Asset Management N.V. Sells 9,014 Shares of Biogen Inc. $BIIB - MarketBeat
Will Biogen Inc. stock go up soon2025 Market Overview & Fast Moving Market Watchlists - Newser
Developing predictive dashboards with Biogen Inc. data2025 Top Decliners & Low Risk Growth Stock Ideas - Newser
Can volume confirm reversal in Biogen Inc.July 2025 Earnings & Consistent Growth Equity Picks - Newser
Biogen Inc. stock daily chart insights2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - Newser
Biogen’s Zurzuvae and the Expanding Postnatal Depression Treatment Market: A Catalyst for Long-Term Growth in Maternal Mental Health - AInvest
Biogen Inc. $BIIB Shares Sold by Northern Trust Corp - MarketBeat
Level Four Advisory Services LLC Buys 8,685 Shares of Biogen Inc. $BIIB - MarketBeat
Multi factor analysis applied to Biogen Inc.2025 Top Gainers & Verified Entry Point Signals - Newser
Dimensional Fund Advisors LP Reduces Holdings in Biogen Inc. $BIIB - MarketBeat
Quantbot Technologies LP Grows Position in Biogen Inc. $BIIB - MarketBeat
UK Regulator Approves Biogen’s Drug For Treating Postnatal Depression - MSN
Biogen Dips 0.26% as $0.19B Volume Ranks 491st in Market Activity Amid Global Smart Shelves Market Surge - AInvest
Can trapped investors hope for a rebound in Biogen Inc.Earnings Miss & Real-Time Volume Analysis Alerts - Newser
Biogen wins approval of postpartum depression drug Zurzuvae in UK - Seeking Alpha
Analyzing drawdowns of Biogen Inc. with statistical toolsEarnings Overview Summary & Weekly Sector Rotation Insights - Newser
Biogen Partnership and Zorevunersen Data Could Be a Game Changer for Stoke Therapeutics (STOK) - simplywall.st
Biogen Inc. $BIIB Shares Sold by Price T Rowe Associates Inc. MD - MarketBeat
Biotech Movers: Novavax Falls Again After New Data on RSV Vaccine Fails to Excite - TheStreet
Biogen Inc (BIIB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
자본화:
|
볼륨(24시간):